Showing results (411-420 of 1,188) with videos related to

Sort By:
Pageof 119
Blood|November 2, 2002
Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignanciesJorge Cortes, Maher Albitar, Deborah Thomas, et al.
Therapeutic Advances in Hematology|April 2, 2014
Outcomes of patients with myelodysplatic syndrome and chronic myelomonocytic leukemia post clofarabine failureHady Ghanem, Guillermo Garcia-Manero, Stefan Faderl, et al.
Leukemia Research|July 6, 2004
Extramedullary relapse in a patient with acute promyelocytic leukemia: successful treatment with arsenic trioxide, all-trans retinoic acid and gemtuzumab ozogamicin therapiesApostolia-Maria Tsimberidou, Elihu Estey, Gary J Whitman, et al.
Blood|July 31, 2013
Clinical characteristics and outcomes of therapy-related chronic myelomonocytic leukemiaKoichi Takahashi, Naveen Pemmaraju, Paolo Strati, et al.
The Journal of Antimicrobial Chemotherapy|May 14, 2019
Antifungal activity and killing kinetics of anidulafungin, caspofungin and amphotericin B against Candida aurisCatiana Dudiuk, Indira Berrio, Florencia Leonardelli, et al.
Pediatric Nephrology (Berlin, Germany)|March 10, 2009
Screening for kidney disease in children on World Kidney Day in Jalisco, MexicoSusan M Koshy, Guillermo Garcia-Garcia, Jacob Sandoval Pamplona, et al.
Haematologica|October 15, 2020
The effect of eltrombopag in managing thrombocytopenia associated with tyrosine kinase therapy in patients with chronic myeloid leukemia and myelofibrosisMahran Shoukier, Gautam Borthakur, Elias Jabbour, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 3, 2014
A phase I/II study of the Janus kinase (JAK)1 and 2 inhibitor ruxolitinib in patients with relapsed or refractory acute myeloid leukemiaNaveen Pemmaraju, Hagop Kantarjian, Tapan Kadia, et al.
Current Research in Food Science|May 8, 2023
Use of industry 4.0 technologies to reduce and valorize seafood waste and by-products: A narrative review on current knowledgeAbdo Hassoun, Janna Cropotova, Hana Trollman, et al.
Leukemia & Lymphoma|January 12, 2018
Safety profile of lenalidomide in patients with lower-risk myelodysplastic syndromes without del(5q): results of a phase 3 trialAntonio Almeida, Pierre Fenaux, Guillermo Garcia-Manero, et al.
Pageof 119